Analysis of essential medicines use in elderly patients with common chronic disease
Objective To assess the applicability of the national essential medicines list in elderly patients with common chronic diseases,providing a reference for strengthening the management of essential medicines,selecting national essential medicines,and improving relevant policies.Methods The survey was conducted among elderly patients with common chron-ic diseases in 15 medical institutions of different levels in 7 regions of China,aimed at gathering basic information,disease in-formation and medication lists of elderly patients with common chronic diseases,followed by statistical analysis of the collect-ed data.Results A total of 1053 valid questionnaires were collected with an average of 2.8 diseases per patient.There were 3952 instances of medication use,averaging 3.8 medications per person.Among these,basic medications were used in 2761 instances(69.9%,2761/3952),and the proportion of patients who used at least one essential drug was 92.6%(975/1053).Drugs with the highest frequency of use mainly included antiplatelet drugs,hypoglycemic drugs,antihypertensive drugs,and lipid-adjusting drugs.The top 10 drugs in the ranking were aspirin,atorvastatin,metformin,metoprolol,amlodipine,nifedipine,rosuvastatin,clopidogrel,acarbose,and insulin,most of which were listed as national essential medicines.Conclusion The utilization rate of national essential medicine use among elderly patients was relatively high,and they are the core drugs in medication therapy management for the elderly.Strengthening the selection,dynamic adjustment and use of essential medi-cines is of great significance to clinical safety,effectiveness,rationality and economical use.